Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review
Therapeutic Advances in Psychopharmacology 2023 F. Jollant, R. Colle, Thi Mai Loan Nguyen et al.
Background: More than 2% of the general population experience suicidal ideas each year and a large number of them will attempt suicide. Evidence-based therapeutic options to manage suicidal crisis are currently limited. Objectives: The aim of this study was to overview the findings on the use of ketamine and esketamine for the treatment of suicidal ideas and acts. Design: Systematic review....